Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells.
Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells.
复制标题
DOI:
10.1371/journal.pgen.1009708
复制
发表时间:
2021-07
期刊:
影响因子:
4.5
通讯作者:
Hollenhorst PC
中科院分区:
文献类型:
--
作者:
Strittmatter BG;Jerde TJ;Hollenhorst PC
The TMPRSS2/ERG gene rearrangement occurs in 50% of prostate tumors and results in expression of the transcription factor ERG, which is normally silent in prostate cells. ERG expression promotes prostate tumor formation and luminal epithelial cell fates when combined with PI3K/AKT pathway activation, however the mechanism of synergy is not known. In contrast to luminal fates, expression of ERG alone in immortalized normal prostate epithelial cells promotes cell migration and epithelial to mesenchymal transition (EMT). Migration requires ERG serine 96 phosphorylation via endogenous Ras/ERK signaling. We found that a phosphomimetic mutant, S96E ERG, drove tumor formation and clonogenic survival without activated AKT. S96 was only phosphorylated on nuclear ERG, and differential recruitment of ERK to a subset of ERG-bound chromatin associated with ERG-activated, but not ERG-repressed genes. S96E did not alter ERG genomic binding, but caused a loss of ERG-mediated repression, EZH2 binding and H3K27 methylation. In contrast, AKT activation altered the ERG cistrome and promoted expression of luminal cell fate genes. These data suggest that, depending on AKT status, ERG can promote either luminal or EMT transcription programs, but ERG can promote tumorigenesis independent of these cell fates and tumorigenesis requires only the transcriptional activation function. ERG is the most common oncogene in prostate cancer. The ERG protein can bind DNA and can activate some genes and repress others. Previous studies indicated that ERG cannot promote cancer by itself, but that ERG works together with mutations that activate the protein AKT. In this study we found that activation of AKT changes the genes that ERG regulates, leading to luminal epithelial differentiation, which is a hallmark of most prostate tumors. However, we also found that a mutant version of ERG that can activate, but cannot repress genes, can drive prostate tumorigenesis without activation of AKT, but this mutant ERG cannot promote luminal differentiation. Our findings suggest that ERG mediated tumorigenesis only requires ERG’s activation function and can occur independent of luminal cell differentiation.
登录
查看更多内容
影响因子:
30.8
作者:
Carver, Brett S.;Tran, Jennifer;Gopalan, Anuradha;Chen, Zhenbang;Shaikh, Safa;Carracedo, Arkaitz;Alimonti, Andrea;Nardella, Caterina;Varmeh, Shohreh;Scardino, Peter T.;Cordon-Cardo, Carlos;Gerald, William;Pandolfi, Pier Paolo
通讯作者:
Pandolfi, Pier Paolo
DOI:
10.1126/science.1189992
发表时间:
2010-07-30
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Goldstein AS;Huang J;Guo C;Garraway IP;Witte ON
通讯作者:
Witte ON
DOI:
10.1158/1078-0432.ccr-18-0653
发表时间:
2018-09-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Blee AM;He Y;Yang Y;Ye Z;Yan Y;Pan Y;Ma T;Dugdale J;Kuehn E;Kohli M;Jimenez R;Chen Y;Xu W;Wang L;Huang H
通讯作者:
Huang H
影响因子:
64.5
作者:
Cancer Genome Atlas Research Network
通讯作者:
Cancer Genome Atlas Research Network
影响因子:
2.9
作者:
Adamo, Patricia;Porazinski, Sean;Ladomery, Michael R.
通讯作者:
Ladomery, Michael R.